WB-4101

N/A

Report date: 2022/09/08 10:54:25

Base Information

Drug NameWB-4101
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonists
TargetsAdrenergic receptors alpha-1
Therapy Area/IndicationsReperfusion InjuryHypertensionArrhythmias, Cardiac +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsN/A
Inactive IndicationsReperfusion InjuryHypertensionArrhythmias, Cardiac +[4] 

Other Information

ATC CodeN/A
Related LinksN/A